The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Lehigh Valley’s health networks are seeing abnormally high cases of the stomach bug that’s taking a large number of people out of action and leaving them stuck in the bathroom. Nationwide, outbreaks ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Unless they’re covering me in a cloud of norovirus particles. When the violent expelling of liquid starts somewhere other ...

You can also get norovirus by touching objects or surfaces that are contaminated and then putting your hands in your mouth ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Health officials are continuing to track a rise in norovirus cases. They warn that hand sanitizer does not work against it.

Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...